Suven Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
322.86
271.84
248.85
269.98
234.16
Other Income Qtr Cr15.7114.1218.1617.0514.34
Operating Revenues Qtr307.15257.72230.69252.93219.82

*All values are in Cr.

Operating Expenses Qtr
189.45
153.71
150.76
179.59
154.68
Operating Profit Qtr
117.70
104.01
79.93
73.34
65.14
EBIDT Qtr Cr
133.41
118.13
98.09
90.40
79.49
Depreciation Qtr
20.35
16.96
13.40
17.25
12.75
Net Profit Qtr
82.88
82.21
60.77
53.37
46.75
Basic EPS Qtr
3.26
3.23
2.39
2.10
1.84
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -